Royal Free Hospital and University College London Medical School
Medical School
Mayo School of Graduate Medical Education
Residency
Mayo School of Graduate Medical Education
Fellowship
MN State Medical License Active through 2012
OH State Medical License Active through 2015
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
Dr. Cheng Chee has contributed to 3 publications.
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Chee CE Krishnamurthi S Nock CJ Meropol NJ Gibbons J Fu P Bokar J Teston L O'Brien T Gudena V Reese A Bergman M Saltzman J Wright JJ Dowlati A Brell J; Oncologist. 2013 .
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Chee CE Krishnamurthi S Nock CJ Meropol NJ Gibbons J Fu P Bokar J Teston L O'Brien T Gudena V Reese A Bergman M Saltzman J Wright JJ Dowlati A Brell J; Oncologist. 2013 .
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.
Hospitals & Clinics
specialties & services
